Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.58449 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.52787 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.53176 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.44624 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.53096 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.7022 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.65765 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.49508 | 58 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.47834 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.40931 | 56 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.4911 | 58 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.35439 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.52074 | 58 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.51887 | 59 |